Acurx Pharmaceuticals Inc... (ACXP)
NASDAQ: ACXP
· Real-Time Price · USD
0.35
0.00 (0.73%)
At close: Jun 06, 2025, 3:59 PM
0.34
-3.38%
After-hours: Jun 06, 2025, 05:57 PM EDT
0.73% (1D)
Bid | 0.34 |
Market Cap | 8.27M |
Revenue (ttm) | n/a |
Net Income (ttm) | -11.88M |
EPS (ttm) | -0.7 |
PE Ratio (ttm) | -0.5 |
Forward PE | -0.67 |
Analyst | Buy |
Ask | 0.36 |
Volume | 151,101 |
Avg. Volume (20D) | 193,176 |
Open | 0.35 |
Previous Close | 0.35 |
Day's Range | 0.34 - 0.35 |
52-Week Range | 0.30 - 3.33 |
Beta | -1.37 |
About ACXP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACXP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACXP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-29.86%
Acurx Pharmaceuticals shares are trading lower aft...
Unlock content with
Pro Subscription
5 months ago
-26.01%
Acurx Pharmaceuticals shares are trading lower after the company announced a $2.5 million registered direct offering.

3 weeks ago · seekingalpha.com
Acurx Pharmaceuticals, Inc. (ACXP) Q1 2025 Earnings Call TranscriptAcurx Pharmaceuticals, Inc. (NASDAQ:ACXP ) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET Company Participants Robert Shawah - Co-Founder and CFO David Luci - President and CEO Conference Ca...

2 months ago · seekingalpha.com
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2024 Earnings Call TranscriptAcurx Pharmaceuticals, Inc. (NASDAQ:ACXP ) Q4 2024 Earnings Conference Call March 18, 2025 8:00 AM ET Company Participants Robert Shawah - Co-Founder and Chief Financial Officer David Luci - President...